35 completed, 9 unknown, 6 withdrawn, 4 active not recruiting. 59 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 59 | Completed 35, Unknown 9, Withdrawn 6, Active not recruiting 4, Terminated 4, Suspended 1 |
Follow End Stage Renal Disease: new trials by email Literature Review of End Stage Renal Disease trials Research Report on End Stage Renal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of L-methylfolate and Methylcobalamine in Treating Resistant Hypertension Associated With Elevated Serum Homocysteine in Hemodialysis Patients. L-Methyl Folate and methylcobalamine - End Stage Renal Disease, Hypertension, Renal | Phase 4 | Completed | Alexandria University | 51 | 2023-04-01 | 2025-01-13 |
| One-month Latent Tuberculosis Treatment for Renal Transplant Candidates 1 month Rifapentine, Isoniazid and Vitamin B6 - Latent Tuberculosis, End Stage Renal Disease | Phase 4 | Active not recruiting | Rutgers, The State University of New Jersey | 25 | 2022-07-01 | 2026-01-21 |
| Triferic AVNU Infusion Via Freedom Pump During Hemodialysis Triferic AVNU - End Stage Renal Disease | Phase 4 | Completed | Rockwell Medical Technologies, Inc. | 12 | 2021-04-19 | 2022-02-28 |
| Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors Glecaprevir/pibrentasvir - End Stage Renal Disease, Hepatitis C | Phase 4 | Completed | Johns Hopkins University | 10 | 2020-11-20 | 2024-01-10 |
| Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access Glecaprevir / Pibrentasvir Oral Tablet [Mavyret] - End Stage Renal Disease, Chronic Hepatitis c | Phase 4 | Withdrawn | Massachusetts General Hospital | 2020-11-13 | 2022-03-08 | |
| The Danish Pre-HCQ COVID Dialysis Study Hydroxychloroquine - COVID-19, End Stage Renal Disease | Phase 4 | Withdrawn | Nicholas Carlson | 2020-04-10 | 2026-05-19 | |
| Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients Spironolactone, Losartan - End Stage Renal Disease, Peritoneal Dialysis | Phase 4 | Unknown | Chiang Mai University | 84 | 2019-10-01 | 2019-09-04 |
| The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients Olimel N12, Glucose IV - End Stage Renal Disease, Malnutrition | Phase 4 | Active not recruiting | Erasmus Medical Center | 166 | 2019-09-16 | 2026-02-12 |
| Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients Sodium Bicarbonate 7.5% Injection, Heparin Sodium, 1000 Units/mL Injectable Solution 1 - End Stage Renal Disease, Vascular Access Complication | Phase 4 | Unknown | Hospital General "Dr. Miguel Silva" de Morelia | 60 | 2019-09-11 | 2020-04-30 |
| Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients Patiromer Oral Powder Product - Hyperkalemia, End Stage Renal Disease | Phase 4 | Completed | Duke University | 36 | 2019-06-20 | 2025-05-30 |
| A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP Tenapanor, Sevelamer Carbonate - Hyperphosphatemia, End Stage Renal Disease | Phase 4 | Completed | Ardelyx | 172 | 2019-06-15 | 2023-03-29 |
| Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors 300mg glecaprevir/pibrentasivir 120mg - End Stage Renal Disease, Hepatitis C | Phase 4 | Completed | Johns Hopkins University | 11 | 2018-09-25 | 2021-10-19 |
| Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients Tacrolimus Extended-Release Oral Capsule - End Stage Renal Disease | Phase 4 | Completed | Cedars-Sinai Medical Center | 20 | 2017-09-11 | 2022-01-19 |
| Ferric Citrate in ESRD Pilot Project Ferric Citrate - End Stage Renal Disease, Chronic Kidney Diseases | Phase 4 | Active not recruiting | Sreedhar Mandayam | 30 | 2017-05-11 | 2019-04-17 |
| Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation apixaban, warfarin - Atrial Fibrillation, End Stage Renal Disease | Phase 4 | Completed | Christopher Granger, MD | 154 | 2016-12-01 | 2020-12-29 |
| Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation Sodium Bicarbonate Catheter Lock Solution, Normal Saline Catheter Lock Solution - End Stage Renal Disease, Acute Renal Failure | Phase 4 | Completed | Coney Island Hospital, Brooklyn, NY | 451 | 2016-10-01 | 2018-08-14 |
| Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection Chlorhexidine gluconate-soaked cloths, Normal saline, mupirocin ointment - End Stage Renal Disease, Peritoneal Dialysis | Phase 4 | Unknown | Chiang Mai University | 354 | 2016-06-01 | 2019-07-29 |
| Bupropion for Depression in ESRD Patients on Hemodialysis Fluoxetine, Bupropion - Major Depression, End Stage Renal Disease | Phase 4 | Terminated | University of Arkansas | 1 | 2016-03-31 | 2018-07-17 |
| A Study of Ferric Citrate to Improve Inflammation and Lipid Levels Ferric Citrate - End Stage Renal Disease, Hyperphosphatemia | Phase 4 | Terminated | Winthrop University Hospital | 38 | 2015-07-01 | 2023-04-20 |
| The Use of Furosemide in Patients on Dialysis Withdrawal of furosemide, furosemide administration - End Stage Renal Disease | Phase 4 | Unknown | Unity Health Toronto | 51 | 2015-05-01 | 2016-08-10 |
Showing 20 of 59. Sign in to see all of them.
Kidney Failure, Chronic (59) · Cardiovascular Diseases (4) · Hyperparathyroidism, Secondary (4) · Anemia (3) · Hepatitis C (3) · Hepatitis C, Chronic (3) · Hypertension (3) · Peritonitis (3) · Renal Insufficiency, Chronic (3) · Catheter-Related Infections (2) · Hyperphosphatemia (2) · Hypertrophy, Left Ventricular (2) · Kidney Diseases (2) · Acute Coronary Syndrome (1) · Acute Kidney Injury (1)
Chronic Disease (59) · Disease Attributes (59) · Female Urogenital Diseases (59) · Female Urogenital Diseases and Pregnancy Complications (59) · Male Urogenital Diseases (59) · Pathologic Processes (59) · Pathological Conditions, Signs and Symptoms (59) · Renal Insufficiency (59) · Urogenital Diseases (59) · Urologic Diseases (59) · Kidney Diseases (57) · Renal Insufficiency, Chronic (56) · Infections (11) · Digestive System Diseases (8) · Cardiovascular Diseases (7)
Tacrolimus (4) · Spironolactone (3) · glecaprevir and pibrentasvir (3) · Cinacalcet (2) · Cyclosporine (2) · Mycophenolic Acid (2) · Vitamin B 6 (2) · Vitamin D (2) · ferric citrate (2) · glecaprevir (2) · 1-((2-hydroxyethyl)amino)-2-amino-1,2-dideoxyglucose triphenyltin(IV) (1) · 5-methyltetrahydrofolate (1) · Abatacept (1) · Allopurinol (1) · Antilymphocyte Serum (1)
Amgen (3) · Chiang Mai University (2) · Johns Hopkins University (2) · Vantive Health LLC (2) · Yonsei University (2) · Abbott (1) · Albany College of Pharmacy and Health Sciences (1) · Alexandria University (1) · Ardelyx (1) · Baxter Healthcare Corporation (1) · Brigham and Women's Hospital (1) · Cedars-Sinai Medical Center (1) · Chang Gung Memorial Hospital (1) · Chiesi Farmaceutici S.p.A. (1) · Chinese University of Hong Kong (1)
United States (24) · China (4) · South Korea (4) · Canada (3) · Taiwan (3) · Thailand (3) · Mexico (2) · Australia (1) · Austria (1) · Colombia (1) · Denmark (1) · Egypt (1) · France (1) · Hong Kong (1) · Iran (1)
Allan D Struthers, BSc, MD, FRCP, FESC, FRSE (1) · Arjang Djamali, M.D. (1) · Bon Nyeo Koo, MD, Ph.D (1) · Candace Grant, MD (1) · Chen-Hua Liu, M.D. (1) · Cheuk Chun Szeto, MD (1) · Chidchanok Ruengorn (1) · Christine Durand, MD (1) · Christopher Granger, MD (1) · Dana Miskulin, MD (1) · David P Rosenbaum, PhD (1)
PMID 33586138, PMID 38899545, PMID 11562419, PMID 15385656, PMID 18178780, PMID 18178950, PMID 18587236, PMID 19365139, PMID 21388319, PMID 22134627, PMID 22863242, PMID 23474008, PMID 23594858, PMID 25398129, PMID 26086833, PMID 26270340, PMID 27581438, PMID 28151412, PMID 28342282, PMID 29424935, PMID 30668833, PMID 30723975, PMID 31299919, PMID 31672793, PMID 31856900, PMID 32588430, PMID 32894697, PMID 36017158, PMID 36335914, PMID 37096802, PMID 37853560, PMID 38323855, PMID 41580678
2004 (1), 2014 (1), 2018 (1), R21DK097470 (1)